Drug target · ADRA1A
alpha-1A adrenoceptor
Alpha-1A adrenergic receptor
5 compounds in the CNS pipeline act on alpha-1A adrenoceptor.
Compounds targeting alpha-1A adrenoceptor
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| TNX-102 SL (cyclobenzaprine HCl sublingual)Small molecule | Antagonist | Ki 5.6 nM | ApprovedFibromyalgia | Tonix Pharmaceuticals Holding Corp. |
| Olanzapine extended-release injectable suspension (TEV-'749)Small molecule | Antagonist | — | Filed (NDA)Schizophrenia | Teva Pharmaceutical Industries Ltd. |
| Iloperidone LAISmall molecule | Antagonist | Ki 0.36 nM | Phase 3Schizophrenia | Vanda Pharmaceuticals Inc. |
| Milsaperidone (VHX-896)Small molecule | Antagonist | Ki 8.3 nM | Phase 3Major depressive disorder | Vanda Pharmaceuticals Inc. |
| Roluperidone (MIN-101)Small molecule | Antagonist | Ki 4.17 nM | Phase 3Schizophrenia | Minerva Neurosciences, Inc. |